Literature DB >> 11486162

Treatment of secondary lymphedema of the arm with physical decongestive therapy and sodium selenite: a review.

R G Kasseroller1, G N Schrauzer.   

Abstract

Secondary lymphedema (LE) in the proximal extremities develop with relatively high frequency in cancer patients after tumor resection, lymph-node obliteration, and/or postoperative irradiation. Physical therapy combined with manual or mechanical lymph drainage and compression bandaging provides symptomatic relief but does prevent the progression of degenerative changes in the affected tissues. As biochemical studies have linked these changes significantly to the excessive generation of oxygen radicals in the affected tissues, LE therapy should aim to eliminate oxygen radical production. Because selenium is a functional component of antioxidant enzymes, has anti-inflammatory properties, and reduces the expression of endothelial cell adhesion molecules, its effect was investigated in postmastectomy patients with LE of the arm. Sodium selenite administered orally in isotonic solution (selenase) at oral dosages of 800 microg Se/day on days 1 through 4 and 500 microg Se/day on days 5 through 28 produced a spontaneous reduction in LE volume and normalized blood parameters in a manner consistent with diminished oxygen radical production. In a randomized, placebo-controlled, double-blind study with postmastectomy LE patients undergoing combined physical decongestion therapy (CPDT), selenite at similar dosages increased the efficacy of CPDT and improved the mobility and heat tolerance of the affected extremity. The patients in this study received 1000 microg of Se/day orally during the first week, 300 microg Se/day during the second and third weeks, and a maintenance dose of 100 microg Se/day during 3 months of follow-up. All patients remained erysipelas-free during the 3 weeks of CPDT and the 3-month follow-up period. Based on the available evidence, supplementation with sodium selenite in isotonic solution is judged to be a valuable and safe extension of the physical decongestive therapy of LE.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11486162     DOI: 10.1097/00045391-200007040-00008

Source DB:  PubMed          Journal:  Am J Ther        ISSN: 1075-2765            Impact factor:   2.688


  10 in total

1.  Evidence-Based Complementary Medicine in Breast Cancer Therapy.

Authors:  Josef Beuth
Journal:  Breast Care (Basel)       Date:  2009-02-20       Impact factor: 2.860

Review 2.  The role of selenium in inflammation and immunity: from molecular mechanisms to therapeutic opportunities.

Authors:  Zhi Huang; Aaron H Rose; Peter R Hoffmann
Journal:  Antioxid Redox Signal       Date:  2012-01-09       Impact factor: 8.401

3.  A prospective randomised study of alginate-drenched low stretch bandages as an alternative to conventional lymphologic compression bandaging.

Authors:  Renato G Kasseroller; Erich Brenner
Journal:  Support Care Cancer       Date:  2009-05-31       Impact factor: 3.603

Review 4.  Selenium for alleviating the side effects of chemotherapy, radiotherapy and surgery in cancer patients.

Authors:  G Dennert; M Horneber
Journal:  Cochrane Database Syst Rev       Date:  2006-07-19

5.  [Secondary malignant lymphedema in head and neck tumors].

Authors:  Bernhard Hammerl; Walter Döller
Journal:  Wien Med Wochenschr       Date:  2008

6.  Intravenous pamidronate for refractory lymphedema.

Authors:  A A Beigi; A M Sadeghi; H Masoudpour; S Shirazinejad; P Mottaghi
Journal:  Iran Red Crescent Med J       Date:  2011-04-01       Impact factor: 0.611

7.  Selenium Deficiency in Lymphedema and Lipedema-A Retrospective Cross-Sectional Study from a Specialized Clinic.

Authors:  Christina Pfister; Horst Dawczynski; Franz-Josef Schingale
Journal:  Nutrients       Date:  2020-04-25       Impact factor: 5.717

8.  Sodium Selenite Alleviates Breast Cancer-Related Lymphedema Independent of Antioxidant Defense System.

Authors:  Hye Won Han; Eun Joo Yang; Seung-Min Lee
Journal:  Nutrients       Date:  2019-05-07       Impact factor: 5.717

Review 9.  Pharmacotherapy Agents in Lymphedema Treatment: A Systematic Review.

Authors:  Antonio J Forte; Daniel Boczar; Maria T Huayllani; Xiaona Lu; Sarah A McLaughlin
Journal:  Cureus       Date:  2019-12-05

Review 10.  Emerging Anti-Inflammatory Pharmacotherapy and Cell-Based Therapy for Lymphedema.

Authors:  Ryohei Ogino; Tomoharu Yokooji; Maiko Hayashida; Shota Suda; Sho Yamakawa; Kenji Hayashida
Journal:  Int J Mol Sci       Date:  2022-07-09       Impact factor: 6.208

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.